This is a professional biopharma plant project, dedicated to providing a comprehensive, compliant, and high-standard production base for biopharmaceutical products such as recombinant proteins, therapeutic antibodies, and biological vaccines. The plant is designed and constructed with a focus on advanced bioprocess and strict sterility control, integrating cutting-edge biomanufacturing technology, precision equipment, and scientific management systems to ensure the safe, sterile, and efficient production of high-quality biopharmaceutical products.
Bioprocess is the core competitiveness of the biopharma plant, covering the entire biomanufacturing lifecycle from cell culture, fermentation, and purification to formulation and filling. We adopt optimized bioprocess design, combining advanced cell culture technologies, high-efficiency fermentation systems, and precision purification processes to maximize product yield and purity while maintaining the biological activity of target products. Each link of the bioprocess is strictly controlled and monitored, ensuring stability, reproducibility, and compliance with global biopharmaceutical standards.
Sterility is the fundamental requirement for biopharma plant operation, as biopharmaceutical products are highly sensitive to microbial contamination, which directly affects product safety and efficacy. We implement rigorous sterility control measures throughout the entire plant design, construction, and production process. The plant is equipped with high-grade cleanrooms, configured with HEPA filters, laminar flow systems, and real-time environmental monitoring equipment to strictly control particle count, microbial load, and other key indicators. All production equipment, pipelines, and materials undergo strict sterilization processes, and sterile operation specifications are strictly followed to completely eliminate the risk of contamination.
The biopharma plant strictly adheres to global regulatory requirements such as FDA cGMP, EU GMP, and China GMP, integrating strict quality management systems and full-process traceability mechanisms. We also integrate professional containment and isolation measures into the bioprocess to protect both the integrity of biopharmaceutical products and the safety of operators. With advanced bioprocess design, strict sterility control, and standardized management, the plant provides a reliable production platform for biopharmaceutical enterprises, helping them achieve compliant, sterile, and efficient biomanufacturing.
